Form 4 for ADMA ADMA BIOLOGICS, INC.
Accepted 2026-03-17 00:00:00 ET · period of report 2026-03-13 · accession 0001140361-26-009900 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2026-03-17 | 2026-03-17 | ADMA | Guiheen Lawrence P. | Dir | G - Gift | $0.00 | +30.0K | 30.0K | New | $0 |
| D | 2026-03-17 | 2026-03-17 | ADMA | Guiheen Lawrence P. | Dir | G - Gift | $0.00 | -30.0K | 105.5K | -22% | $0 |
| D | 2026-03-17 | 2026-03-13 | ADMA | Guiheen Lawrence P. | Dir | M - OptEx | $3.66 | +30.0K | 135.5K | +28% | +$109.8K |
| D | 2026-03-17 | 2026-03-13 | ADMA | Guiheen Lawrence P. | Dir | M - OptEx | $0.00 | -30.0K | 23.8K | -56% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-17 | G | A | 30,000 | $0.00 | 30,000 | I | — | — | |
| 2 | Common | Common Stock | 2026-03-17 | G | D | 30,000 | $0.00 | 105,520 | D | — | — | (F1) Includes, as of the transaction date, (i) 10,690 RSUs granted on February 9, 2026, which will fully vest on February 9, 2027, subject to the Reporting Person's continued service as of such vesting date; and (ii) 94,830 shares of common stock owned by the Reporting Person. |
| 3 | Common | Common Stock | 2026-03-13 | M | A | 30,000 | $3.66 | 135,520 | D See footnote | — | — | (F1) Includes, as of the transaction date, (i) 10,690 RSUs granted on February 9, 2026, which will fully vest on February 9, 2027, subject to the Reporting Person's continued service as of such vesting date; and (ii) 94,830 shares of common stock owned by the Reporting Person. (F3) Includes 30,000 shares of common stock held in the 2019 Guiheen Irrevocable Trust. |
| 4 | Derivative | Stock Option (Right to Buy) | 2026-03-13 | M | D | 30,000 | $0.00 | 23,837 | D | $3.66 · — to 2027-06-06 | 30,000 Common Stock | (F5) The Reporting Person is exercising this option due, in part, to its near-term expiration date. (F6) These options vested in twenty-four equal monthly installments, becoming fully vested on the one-year anniversary of the date of grant. |